🧬🔬 Introducing #drivingCGT 🌟🏎️ At Miltenyi Biotec, we're driven by a passion for advancing cell and gene therapies (CGT). For over 30 years, we've dedicated ourselves to pioneering technologies that propel CGT developments. Our #drivingCGT series provides you diverse perspectives on how we and our customers shape the future of CGT. From pioneering researchers to dedicated clinical scientists and visionary industry experts, each individual voice in #drivingCGT shares a common goal: the relentless fight against cancer & other diseases. How are you #drivingCGT? Tell us about it in the comments 🌟🏎️ #drivingCGT #MiltenyiBiotec #FightAgainstCancer #InnovationInTherapy
Miltenyi Biotec
Ricerca biotecnologica
Bergisch Gladbach, North Rhine-Westphalia 78.123 follower
Empowering discovery. Advancing therapy.
Chi siamo
For over 30 years, Miltenyi Biotec has been a major provider of products and services that drive biomedical research and boost cell and gene therapy. More than 4,700 employees in 23 countries combine excellence in research with innovative products to create cutting-edge solutions that make cancer and other disease history. Our expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. At Miltenyi Biotec, scientists, engineers, software developers and many other professionals work together to improve human health by providing smarter cellular technology solutions to researchers and clinicians worldwide.
- Sito Web
-
http://www.miltenyibiotec.com
Link esterno per Miltenyi Biotec
- Settore
- Ricerca biotecnologica
- Dimensioni dell’azienda
- 1001 - 5000 dipendenti
- Sede principale
- Bergisch Gladbach, North Rhine-Westphalia
- Tipo
- Società privata non quotata
- Data di fondazione
- 1989
- Settori di competenza
- Immunology, Stem Cell Research, Cancer Research, Neuroscience, Cell Isolation, Cell Sorting, Sample Preparation, Tissue Dissociation, Cell Culture, Cytokines, Antibodies, Imaging Agents, Molecular Analysis, Clinical Applications, Basic Research e Translational Research
Località
Dipendenti presso Miltenyi Biotec
Aggiornamenti
-
🎉 What a fantastic milestone! Congratulations to Adaptimmune on paving the way for solid tumor treatments using TCR T cell therapy!
#BreakingNews We’ve received U.S. FDA accelerated approval for the first engineered cell therapy for the treatment of a solid tumor cancer. #CellTherapy #Biotech #Innovation #Oncology #CancerCare Press Release Link: https://lnkd.in/gp68yd6U
-
-
The colorful and data rich world of spatial biology is within your reach! 👩🔬✨ The MACSima™ Platform is the open platform to start your exploration of new and unseen oceans of high-plex imaging data. Learn more now to dive deep into spatial biology! 👉 https://ow.ly/NTxH50SFYxK #MACSima #SpatialBiology #MiltenyiBiotec
-
Interested in PET imaging of glioblastoma at single cell resolution? Click here to catch Prof. Dr. med. Matthias Brendel webinar, where he merges 3D histology with single-cell analysis post immunomagnetic isolation: https://lnkd.in/gvejez5X #MiltenyiBiotec #MBStories
-
-
We are thrilled to announce that Miltenyi Biotec India has officially signed a Letter of Intent with the Translational Health Science and Technology Institute (THSTI) to strengthen research and development capabilities in cell and gene therapy. This momentous agreement was signed during THSTI's 15th anniversary celebrations, with the esteemed Dr. Jitendra Singh Ji, Hon’ble Minister of State (IC) for the Ministry of Science & Technology and Ministry of Earth Sciences in attendance. THSTI focuses on translating scientific research into medical innovations that benefit society and is part of the Biotechnology Research and Innovation Council, Department of Biotechnology, Ministry of Science, and Technology, Government of India. We are proud of this important partnership which will support the growing need for innovative patient care treatments and accessibility. #MiltenyiBiotec #MiltenyiBiotecIndia #THSTI #CellTherapy #GeneTherapy #CancerResearch #InnovativeMedicine #MedicalAdvancements #ResearchAndDevelopment #ScientificCollaboration #CancerAwareness
-
-
Awesome to see that you had an enlightening and insightful time at the 3rd UK Clinical Bootcamp! We are happy to see the Happy Cell has a new home as the villain that he is.
We had a great time at Miltenyi Biotec 3rd UK Clinical Bootcamp this week. We met with #celltherapy professionals across the UK, learned about new and emerging #cellmanufacturing and quality control approaches and even got a new pair of socks!. Thanks Roanne Jones, PhD FIBMS, Kevin George Faria. MRes Kathryn Gray and Elly Rankin for having us. PS: My Carl Carcinoma plush found his rightful place in my Disney collection next to all the other Disney Villains
-
-
✨ Get the most out of your samples in spatial biology with our all-new MACSwell™ HighRes Slides, the perfect complement to the #MACSima Platform. Explore your samples in unprecedented depth for groundbreaking #SpatialBiology discoveries! 🔍 More info: https://ow.ly/o35C50SxC7y
-
-
Visualizing cells in the context of their environment can put an ocean of data within your view. With over 600 biomarkers available in our MACS® Antibody portfolio, you can see what no one has before and make new discoveries. Our pre-tested antibodies fit seamlessly in any spatial workflow and are suitable for FFPE-, PFA-, or acetone-fixed tissues or cells. If your research is missing depth, take advantage of our limitless proteomics with the MACSima™ Platform. Learn more about antibodies for diving into spatial biology: 👉 https://ow.ly/wZ3B50SCZFa #SpatialBiology #MACSima #highplex #proteomics #antibodypanels
-
-
🎉 Exciting News! 🎉 Congratulations to Liam Reed from the University of Nottingham and Cesar U Monjaras-Avila from the University of British Columbia in Canada for winning the PSC Research Travel Award 2024 with their amazing research. These exceptional researchers have pushed the boundaries of stem cell biology, and we can't wait to see what the future holds for these two talented young scientists! Want to be next year's winner? Stay tuned for more details on the 2025 PSC Travel Award. We are committed to supporting young researchers on their journey to making groundbreaking contributions in their fields. #ISSCR2024 #YoungScientists #TravelAward #MiltenyiBiotec
-
-
Miltenyi Biotec ha diffuso questo post
Global Product Manager | Scientist | Cell Therapy | Gene Therapy | Regenerative Medicine | Product Management | Marketing | Biopharma | Biotechnology
Are you at the #isscr2024 in #Hamburg this week? On Friday at 4:30pm, we will showcase #CliniMACS Prodigy #Demos for human PSC and MSC culture applications. Meanwhile you could also explore our wide range of technologies, including cell culture reagents, flow cytometry, and imaging, for various cell types. if you are interested, come visit the Miltenyi Biotec booth! #isscr2024 #regenerativemedicine #stemcell #celltherapy
-